CEO-After receiving his Doctor of Pharmacy, Ronan LE BOT started his career in the industry. A variety of professional experiences and more particularly with AVENTIS allowed him to gain a highly-specialized expertise in preclinical evaluation of drug candidates. After joining the “Institut d’Administration des Entreprises” (Business Administration Institute), he founded his first CRO (Atlantic Bone Screen, 2005) then developed a subsidiary with another CRO AtlanChim Pharma (2008) before setting up a Research & Development company (Atlanthéra, 2009) and to federate all the companies under the AtlAntA group in 2011.